Clinical Trial Update: A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating carilizumab in combination with apatinib for unresectable undifferentiated pleomorphic sarcoma and alveolar soft part sarcoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Apatinib (apatinib)
• Carilizumab (Carilizumab)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN